Wulff, Hansen & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.29M Sell
9,032
-353
-4% -$82.3K 1.76% 15
2026
Q1
$2.29M Sell
9,385
-90
-0.9% -$21K 2.34% 9
2025
Q4
$1.96M Sell
9,475
-50
-0.5% -$9.89K 1.65% 14
2025
Q3
$1.77M Hold
9,525
1.52% 17
2025
Q2
$1.45M Sell
9,525
-335
-3% -$51.5K 1.25% 23
2025
Q1
$1.64M Sell
9,860
-170
-2% -$26.6K 1.49% 21
2024
Q4
$1.45M Sell
10,030
-250
-2% -$38.7K 1.37% 21
2024
Q3
$1.67M Sell
10,280
-840
-8% -$134K 1.51% 21
2024
Q2
$1.63M Sell
11,120
-70
-0.6% -$10.4K 1.6% 16
2024
Q1
$1.77M Sell
11,190
-250
-2% -$39.8K 1.77% 17
2023
Q4
$1.79M Sell
11,440
-25
-0.2% -$3.83K 1.99% 17
2023
Q3
$1.79M Hold
11,465
2.08% 14
2023
Q2
$1.9M Hold
11,465
2.12% 15
2023
Q1
$1.78M Sell
11,465
-20
-0.2% -$3.23K 2.03% 16
2022
Q4
$2.03M Sell
11,485
-70
-0.6% -$12.1K 2.46% 11
2022
Q3
$1.89M Hold
11,555
2.36% 12
2022
Q2
$2.05M Sell
11,555
-85
-0.7% -$15.1K 2.32% 8
2022
Q1
$2.06M Sell
11,640
-45
-0.4% -$7.66K 1.96% 15
2021
Q4
$2M Buy
+11,685
New +$1.91M 1.73% 21

Other funds holding JNJ

Wulff, Hansen & Co's JNJ Position: Q2 2026 in Review

Wulff, Hansen & Co reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q2 2026, selling an estimated $82.3K and leaving 9,032 shares worth $2.29M. The position accounts for 1.76% of the portfolio, ranked #15.

Wulff, Hansen & Co first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.29M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Wulff, Hansen & Co held 9,032 shares of Johnson & Johnson worth $2.29M as of Q2 2026.
  • Wulff, Hansen & Co sold 353 Johnson & Johnson shares in Q2 2026, an estimated $82.3K.
  • Johnson & Johnson made up 1.76% of Wulff, Hansen & Co's portfolio in Q2 2026, its #15 holding.
  • Wulff, Hansen & Co first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • Wulff, Hansen & Co's Johnson & Johnson position peaked at $2.29M in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Wulff, Hansen & Co's 13F filing for Q2 2026, filed 5 Aug 2026.